assurance complémentaire – Non remboursement de l'analyse du taux de calprotectine fécale.

This written question concerns the non-reimbursement of the analysis of fecal calprotectin levels. It seeks clarification on the conditions and reasons behind this decision. The question is posed to the relevant government minister, likely impacting patients and healthcare providers who rely on this diagnostic test.